Transcenta Holding Limited 創勝集團醫藥有限公司
Pay for financial year ended 2022-12-31
| Name | Last position |
Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|---|
CNY '000 |
||||||||
Directors |
||||||||
| 1 | Bao, Jun (Impact Therapeutics) 包駿 | INED | 200 | 35 | 235 | |||
| 2 | Qian, Xueming 錢雪明 | CEO | 1,608 | 1,261 | 2,224 | 167 | 417 | 5,677 |
| 3 | Shi, Michael Ming 石明 | ED | 2,151 | 2 | 245 | 2,398 | ||
| 4 | Srinivasan, Kumar | INED | ||||||
| 5 | Tang, Jiasong 唐稼松 | INED | 200 | 35 | 235 | |||
| 6 | Weng, Xiaolu 翁曉路 | FD | 2,805 | 1,037 | 106 | 3,948 | ||
| 7 | Zhang, Zhihua (1982) 張志華 | INED | 200 | 35 | 235 | |||
| 8 | Zhao, Jonathan Yining 趙奕寧 | NED, Ch | 670 | 657 | 11 | 1,338 | ||
| 9 | Zhu, Albert Da 朱達 | ED | 973 | 2 | 64 | 1,011 | 2,050 | |
| Total | 2,878 | 7,847 | 3,265 | 593 | 1,533 | 16,116 | ||
Main board pay history
Click on the year-end to see the pay details.
CNY'000
| Year-end | Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | 3,252 | 4,759 | 676 | 375 | 15,338 | 24,400 | Report |
| 2022-12-31 | 2,878 | 7,847 | 3,265 | 593 | 1,533 | 16,116 | Report |
| 2021-12-31 | 1,567 | 6,766 | 4,591 | 446 | 22,764 | 36,134 | Report |
| Total | 7,697 | 19,372 | 8,532 | 1,414 | 39,635 | 76,650 |
Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy